ESR1 and breast cancer: In addition, a significant and inverse association has also been observed between quantitative measurements of ERBB2 gene copy number and ER/progesterone receptor (PR) protein expression levels in breast cancer, which may further explain the relative resistance of HR+/HER2+ tumors to ETs8.